HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.

Abstract
A recently reported multinational, 8-week double-blind, placebo-controlled study assessing the efficacy of alprazolam versus placebo in the treatment of panic disorder indicated significant differences favoring alprazolam. We now report the results of a three-site, 6-week, double-blind, fixed-dose study comparing alprazolam 2 mg, alprazolam 6 mg, and placebo in 94 patients with panic disorder with or without agoraphobia. Both alprazolam treatment groups (6 mg and 2 mg) improved significantly more than did the placebo treatment group on most outcome measures. Only a few statistically significant differences between the 6 mg and 2 mg alprazolam groups were discerned, although the pattern of treatment response across measures suggested a dose effect. Dropouts in the placebo group were primarily due to lack of efficacy and in the alprazolam 6 mg group were due to side effects, which may have contributed to the limited differences between groups at study end. The findings suggest that many patients may require less than 6 mg of alprazolam per day for effective treatment of panic disorder.
AuthorsR B Lydiard, I M Lesser, J C Ballenger, R T Rubin, M Laraia, R DuPont
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 12 Issue 2 Pg. 96-103 (Apr 1992) ISSN: 0271-0749 [Print] UNITED STATES
PMID1573046 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Alprazolam
Topics
  • Adolescent
  • Adult
  • Aged
  • Agoraphobia (blood, drug therapy, psychology)
  • Alprazolam (administration & dosage, adverse effects, pharmacokinetics)
  • Arousal (drug effects)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination
  • Panic Disorder (blood, drug therapy, psychology)
  • Personality Assessment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: